Delivery Order SPE2DP20D0002-SPE2DP24F1227
Award Date 12/14/23
Potential Completion Date 12/19/23
Potential Value $153K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Teva Pharmaceuticals USA, Inc. has been awarded a $1,526,969 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. This delivery order was issued under an existing contract vehicle and will support the immunization programs of the military. Teva will deliver the vaccine products to the agency's location in Parsippany, New Jersey by December 19, 2023. As a major pharmaceutical manufacturer, Teva has extensive experience...
- The Defense Logistics Agency awarded Teva Pharmaceuticals USA, Inc. a firm fixed-price delivery order valued at $165,156.93 for Adenovirus Type 4 vaccine with an ultimate completion date of September 23, 2025. The contract, issued without a set-aside designation, is being performed in Parsippany, New Jersey, where Teva maintains its U.S. headquarters. This delivery order supports the Department of Defense's immunization programs and represents part of Teva's established role as a critical...
- Teva Pharmaceuticals USA, Inc. has been awarded a $305,393.76 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to provide adenovirus type 4 vaccine. Performance will take place in Parsippany, New Jersey through December 2023. This delivery order was issued against an existing contract vehicle and supports the immunization programs of the military. Teva Pharmaceuticals has a history of partnering with subcontractors and receiving contract awards to supply...
- Teva Pharmaceuticals USA, Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical for $2,443,150.08 to supply adenovirus type 4 vaccine. The place of performance is Parsippany, New Jersey and the completion date is December 19, 2023. This delivery order supports the military immunization programs of the Defense Logistics Agency Troop Support Medical by providing the requested adenovirus type 4 vaccine. Teva Pharmaceuticals USA, Inc. is a...
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The firm fixed price order calls for Teva to deliver the pharmaceutical product to a location in Parsippany, New Jersey between August 19 and 25, 2020. No subcontractors or set aside designations were identified. The Defense Logistics Agency Troop Support...
- Teva Pharmaceuticals USA, Inc. has been awarded a $916,181 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. The delivery order was awarded on December 14, 2023 and is to be completed by December 19, 2023. Teva will provide the vaccine from its Parsippany, New Jersey location to support immunization programs of the Defense Logistics Agency Troop Support Medical. As the prime contractor, Teva has extensive experience...
- Teva Pharmaceuticals USA, Inc. was awarded a $660,627.72 firm fixed-price delivery order for Adenovirus Type 4 vaccine, with an ultimate completion date of July 29, 2025. This contract, issued by the Medical Supply Chain division within the Department of Defense, represents a non-set-aside award structured as a delivery order under what appears to be a larger indefinite delivery contract vehicle. The work will be performed in Parsippany, New Jersey, where Teva maintains its primary manufacturing...
- Teva Pharmaceuticals USA, Inc. was awarded a Firm Fixed Price Delivery Order by the Defense Logistics Agency Troop Support Medical to provide Adenovirus Type 4 vaccine in Parsippany, New Jersey. The contract has a potential value of $146,823.93 and a completion date of December 20, 2022. Teva is a foreign-owned, for-profit manufacturer that has a history of providing pharmaceutical products, including vaccines and respiratory treatments, to various federal customers such as the Department of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $141,176.88 firm fixed-price delivery order to provide Adenovirus Type 4 vaccine. This order was not set aside under any special socioeconomic program. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has an extensive history of providing drug products, including vaccines and respiratory medications, to federal agencies such as the Department of Defense...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $146,823.93 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. This order supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis medications for federal customers...